Naymisha Patel
Keine laufenden Positionen mehr
Profil
Naymisha Patel worked as Vice President of Quality Systems at StemCells, Inc. and Vice President of Quality at Ocular Therapeutix, Inc. She completed her undergraduate degree at The California State University and the University of Baroda.
She also earned a Master's in Business Administration from Northcentral University.
Ehemalige bekannte Positionen von Naymisha Patel
| Unternehmen | Position | Ende |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | - |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Corporate Officer/Principal | - |
Ausbildung von Naymisha Patel
| The California State University | Undergraduate Degree |
| University of Baroda | Undergraduate Degree |
| Northcentral University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
